Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Control Intervention1: ATRACURIUM: ATRACURIUM :
INTUBATION DOSE :0.5mg/kg iv
MAINTENANCE DOSE :0.1mg/kg iv
Control Intervention2: CISATRACURIUM: CISATRACURIUM:
INTUBATION DOSE: 0.1mg/kg iv
MAINTENANC
Sponsors
DrAswani Baskaran
Eligibility
Inclusion criteria
Inclusion criteria: ASA I ASA II ASAIII Both elective and emergency procedures
Exclusion criteria
Exclusion criteria: ASAIV Pregnant patients Patients with Bronchial asthma Patients with history of cardiovascular disorders Patients with history of hepatic and renal disorders Patients on medications known to interact with neuromuscular blocking drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset and duration of action of neuromuscular blocking drugTimepoint: Onset of action : time from the administration of drug till TOF0. Duration of action is time from administration of drug till TOF1 | — |
Secondary
| Measure | Time frame |
|---|---|
| Haemodynamic variability ( HR SBP DBP SPO2 ) Histamine release laryngoscopyTimepoint: 10min 20min 30min 45min 60min 75min 90min 105min 120min | — |
Countries
India
Contacts
Public ContactDrAswani Baskaran
Chettinad Hospital and Research Institute
Outcome results
None listed